Literature DB >> 31964646

A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking and Addiction.

Kate Z Peters1, Erik B Oleson2, Joseph F Cheer1.   

Abstract

Cannabis sativa, like all known drugs of abuse, leads to increased dopamine activation within the mesolimbic pathway. Consequent dopamine release within terminal regions of the striatum is a powerful mediator of reward and reinforcement and patterned dopamine release is critical for associative learning processes that are fundamentally involved in addiction. The endocannabinoid system modulates dopamine release at multiple sites, and the receptors, endogenous ligands, and synthetic and metabolic enzymes of the endocannabinoid system may provide key targets for pharmacotherapies to treat disorders of motivation including addiction. Disrupting endocannabinoid signaling decreases drug-induced increases in dopamine release as well those dopamine events evoked by conditioned stimuli during reward seeking. Advances in recording techniques for dopamine are allowing unprecedented examinations of these two interacting systems and elucidating the mechanisms of endocannabinoid modulation of dopamine release in reward and addiction.
Copyright © 2021 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Year:  2021        PMID: 31964646      PMCID: PMC7778214          DOI: 10.1101/cshperspect.a039305

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  9 in total

1.  Cannabis Extract Composition Determines Reinforcement in a Vapor Self-Administration Paradigm.

Authors:  Anand K Muthusamy
Journal:  J Neurosci       Date:  2020-08-12       Impact factor: 6.167

Review 2.  Alcohol Use Disorder: Neurobiology and Therapeutics.

Authors:  Waisley Yang; Rohit Singla; Oshin Maheshwari; Christine J Fontaine; Joana Gil-Mohapel
Journal:  Biomedicines       Date:  2022-05-21

Review 3.  Modulating the Neuromodulators: Dopamine, Serotonin, and the Endocannabinoid System.

Authors:  Kate Z Peters; Joseph F Cheer; Raffaella Tonini
Journal:  Trends Neurosci       Date:  2021-03-03       Impact factor: 16.978

4.  Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions
.

Authors:  Rainer Spanagel
Journal:  Dialogues Clin Neurosci       Date:  2020-09       Impact factor: 5.986

5.  Adolescent Intermittent Ethanol (AIE) Enhances the Dopaminergic Response to Ethanol within the Mesolimbic Pathway during Adulthood: Alterations in Cholinergic/Dopaminergic Genes Expression in the Nucleus Accumbens Shell.

Authors:  Sheketha R Hauser; Patrick J Mulholland; William A Truitt; R Aaron Waeiss; Eric A Engleman; Richard L Bell; Zachary A Rodd
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

6.  Candidate Chinese Herbal Medicine Alleviates Methamphetamine Addiction via Regulating Dopaminergic and Serotonergic Pathways.

Authors:  Qin Ru; Qi Xiong; Xiang Tian; Congyue Xu; Can Li; Lin Chen; Yuxiang Wu
Journal:  Front Mol Neurosci       Date:  2022-03-29       Impact factor: 5.639

7.  Chronic Augmentation of Endocannabinoid Levels Persistently Increases Dopaminergic Encoding of Reward Cost and Motivation.

Authors:  Dan P Covey; Edith Hernandez; Miguel Á Luján; Joseph F Cheer
Journal:  J Neurosci       Date:  2021-07-06       Impact factor: 6.167

8.  Chronic cannabinoid exposure produces tolerance to the dopamine releasing effects of WIN 55,212-2 and heroin in adult male rats.

Authors:  Devan M Gomez; Thomas J Everett; Lindsey R Hamilton; Ajit Ranganath; Joseph F Cheer; Erik B Oleson
Journal:  Neuropharmacology       Date:  2020-10-25       Impact factor: 5.250

Review 9.  Cannabinoid Modulation of Dopamine Release During Motivation, Periodic Reinforcement, Exploratory Behavior, Habit Formation, and Attention.

Authors:  Erik B Oleson; Lindsey R Hamilton; Devan M Gomez
Journal:  Front Synaptic Neurosci       Date:  2021-06-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.